| # | Drug | Count |
|---|---|---|
| 0 | AZATHIOPRINE | 9 |
| 1 | ERYTHROPOIETIN | 9 |
| 2 | MYCOPHENOLATE MOFETIL | 9 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 9 |
| 4 | SODIUM POLYSTYRENE SULFONATE | 9 |
| 5 | ASPIRIN | 8 |
| 6 | ASPIRIN 325 MG | 8 |
| 7 | ASPIRIN 81 MG | 8 |
| 8 | RITUXIMAB | 8 |
| 9 | ALENDRONATE SODIUM | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM POLYSTYRENE SULFONATE | 9 | 0.0056 |
| 1 | LANTHANUM CARBONATE | 5 | 0.0010 |
| 2 | ERYTHROPOIETIN | 9 | 0.0004 |
| 3 | ONASEMNOGENE ABEPARVOVEC-XIOI | 1 | 0.0004 |
| 4 | ALENDRONATE SODIUM TABLET | 5 | 0.0003 |
| 5 | RISDIPLAM | 1 | 0.0002 |
| 6 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 1 | 0.0001 |
| 7 | OFLOXACIN OTIC SOLUTION | 1 | 0.0001 |
| 8 | OFLOXACIN OTIC | 1 | 0.0001 |
| 9 | OFLOXACIN | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Potassium Binder [EPC] | 9 |
| 1 | Purine Antimetabolite [EPC] | 9 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 8 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 8 |
| 5 | Insulin Analog [EPC] | 4 |
| 6 | Vitamin B12 [EPC] | 2 |
| 7 | Vitamin C [EPC] | 2 |
| 8 | Vitamin D [EPC] | 2 |
| 9 | Atypical Antipsychotic [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Potassium Binder [EPC] | 9 | 0.0006 |
| 1 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 2 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 3 | Purine Antimetabolite [EPC] | 9 | 0.0001 |
| 4 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 8 | 0.0000 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 8 | 0.0000 |
| 7 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Partial Opioid Agonist [EPC] | 1 | 0.0000 |
| 9 | Insulin Analog [EPC] | 4 | 0.0000 |